Clinical Trial Update: A Study of HDC/IL-2 Treatment in Chronic Myelomonocytic Leukemia (CMML) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for HDC/IL-2 treatment in chronic myelomonocytic leukemia (CMML) across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelomonocytic Leukemia

Drugs mentioned

• HDC/IL-2

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Leukemia, Myelomonocytic, Chronic | Phase 1, Phase 2 | Status: UNKNOWN